SCHEMBL432006

SCHEMBL432006

CC1(C)CC(=O)C(Cl)C(=O)C1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.54
ALDH1A1 P00352 11/20 0.43
KMT2A Q03164 5/20 0.43
POLB P06746 2/20 0.43
KDM4E B2RXH2 2/20 0.43
TSHR P16473 2/20 0.43
HTT P42858 1/20 0.43
MEN1 O00255 2/20 0.38
HPGD P15428 2/20 0.38
HSD17B10 Q99714 2/20 0.38
CYP2C9 P11712 2/20 0.37
CYP3A4 P08684 1/20 0.37
LMNA P02545 1/20 0.37
CYP2C19 P33261 1/20 0.37
GAA P10253 2/20 0.35
GLA P06280 1/20 0.35
CYP1A2 P05177 1/20 0.35
HIF1A Q16665 1/20 0.35
MAOA P21397 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL368265 0.74 MAPT (0.56) MAPTALDH1A1KMT2APOLBKDM4E
SCHEMBL19784252 0.74
SCHEMBL20036958 0.72 MAPT (0.54) MAPTALDH1A1KMT2APOLBKDM4E
SCHEMBL27498457 0.72 MAPT (0.54) MAPTALDH1A1KMT2APOLBKDM4E
SCHEMBL9348170 0.72 MAPT (0.54) MAPTALDH1A1KMT2APOLBKDM4E
SCHEMBL305185 0.72 MAPT (0.54) MAPTALDH1A1KMT2APOLBKDM4E
SCHEMBL11617099 0.70 MAPT (0.46) MAPTALDH1A1KMT2APOLBKDM4E
SCHEMBL1461355 0.70 MAPT (0.46) MAPTALDH1A1KMT2APOLBKDM4E
SCHEMBL28816949 0.70 MAPT (0.32) MAPT
Bromide SCHEMBL3997504 0.70 MAPT (0.52) MAPTALDH1A1KMT2APOLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 208 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250169514-A1 Materials and Methods for Extending Shelf-Life of Foods JP LABORATORIES, INC. 2025-05-29 US claimed
CN-116916755-A Materials and methods for extending the shelf life of food products JP实验室公司 2023-10-20 CN claimed
WO-1995027009-A1 ANTIFOULING PAINT CONTAINING HALOPEROXIDASES AND METHOD TO DETERMINE HALIDE CONCENTRATIONS STICHTING SCHEIKUNDIG ONDERZOEK IN NEDERLAND (NL) 1995-10-12 WO claimed
US-4937192-A ISOLATION FROM FERMENTATION CULTURE; EFFICIENCY CETUS CORPORATION (US) 1990-06-26 US claimed
US-4707447-A OXIDATION, HALOGENATION CETUS CORPORATION (US) 1987-11-17 US claimed
US-12545945-B2 Methods for detection of rare subpopulations of cells and highly purified composition of cells ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE (US) 2026-02-10 US disclosed
EP-4658755-A2 INHIBITION OF METHANE PRODUCTION IN RUMINANTS Loam Bio Pty Ltd (AU) 2025-12-10 EP disclosed
EP-4622995-A2 MODIFIED PLANTS AND PLANT CELLS No Regrets 2050 Ltd. (GB) 2025-10-01 EP disclosed
EP-4524568-A2 METHODS FOR DETECTION OF RARE SUBPOPULATIONS OF CELLS AND HIGHLY PURIFIED COMPOSITIONS OF CELLS Astellas Institute for Regenerative Medicine (US) 2025-03-19 EP disclosed
WO-2024264021-A9 INHIBITION OF METHANE PRODUCTION IN RUMINANTS LOAM BIO LLC (US) 2025-02-27 WO disclosed
WO-2024264021-A2 INHIBITION OF METHANE PRODUCTION IN RUMINANTS LOAM BIO LLC (US) 2024-12-26 WO disclosed
WO-2024250073-A1 METHANE EMISSION-REDUCING MICROORGANISMS Number 8 Bio Holdings Pty Ltd (AU) 2024-12-12 WO disclosed
US-4351902-A Production of 2-keto-D-gluconic acid and hydrogen peroxide CETUS CORPORATION (US) 1982-09-28 US disclosed
US-4284723-A HALOHYDRIN FORMATION WITH HALOGENATING ENZYME, OXIDIZER, HALIDE ION CETUS CORPORATION (US) 1981-08-18 US disclosed
US-4282324-A Method for producing iodine CETUS CORPORATION (US) 1981-08-04 US disclosed
EP-0028136-A1 Process for the production of D-Glucosone and D-Fructose CETUS CORPORATION (US) 1981-05-06 EP disclosed
US-4247641-A USING A HALOGENATING ENZYME, AN OXIDIZER, AND A HALIDE ION SOURCE TO OBTAIN THE HALOHYDRIN INTERMEDIATE CETUS CORPORATION (US) 1981-01-27 US disclosed
US-4246347-A ENZYMATIC CONVERSION TO D-GLUCOSONE, HYDROGENATION TO D-FRUCTOSE CETUS CORPORATION (US) 1981-01-20 US disclosed
EP-0007176-A2 Method for producing epoxides and glycols from alkenes CETUS CORPORATION (US) 1980-01-23 EP disclosed
US-3954984-A ANTISECRETRETORY AGENTS, CENTRAL NERVOUS SYSTEM DEPRESSANTS RICHARDSON-MERRELL INC. (US) 1976-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12545945-B2 Methods for detection of rare subpopulations of cells and highly purified composition of cells ALDH1A2, EYA3, EYA2 MAPT 2114/4885ALDH1A1 89/4885KMT2A 3722/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.